Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
PR01 - Press Conference
- Type: Press Conference
- Track:
- Presentations: 6
- Coordinates: 9/23/2018, 16:00 - 17:30, Room 202 BD
-
+
Welcome
16:00 - 16:05 | Presenter: Natasha B Leighl
- Abstract
No abstract available for this presentation
-
+
Preview of the WCLC/Key Themes/Practice-Changing Abstracts
16:05 - 16:13 | Presenter: Natasha B Leighl
- Abstract
No abstract available for this presentation
-
+
MTE01 - Preclinical Models of Lung Cancer (Ticketed Session)
- Type: Meet the Expert Session
- Track: Biology
- Presentations: 2
- Coordinates: 9/24/2018, 07:00 - 08:00, Room 206 F
-
+
MTE01.02 - Lung Patient Derived Xenograft and Organoid
07:30 - 08:00 | Presenter: Nadeem Moghal
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA02 - Improving Outcomes for Patients with Lung Cancer
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 12
- Coordinates: 9/24/2018, 10:30 - 12:00, Room 201 BD
-
+
MA02.11 - Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - A Prospective Canadian Study (VALUE)
11:40 - 11:45 | Presenter: Doreen Anuli Ezeife
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 112
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.01-42 - Real-World Evaluation of Tolerability in Older Adult Patients (≥75 Years Old) with EGFR-mutated NSCLC
16:45 - 18:00 | Presenter: Shirley Xue Jiang
- Abstract
Loading... -
+
P1.01-52 - BR-34- Randomized Trial of Durvalumab & Tremelimumab +/- Platinum Chemotherapy in Patients with Metastatic Squamous or Non-Squamous NSCLC
16:45 - 18:00 | Presenter: Swati Kulkarni
- Abstract
Loading... -
+
P1.01-54 - A Phase I/Ib Study of Binimetinib (MEK162), a MEK Inhibitor Plus Carboplatin/Pemetrexed in Non-Squamous NSCLC
16:45 - 18:00 | Author(s): Donna Graham
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 45
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.13-11 - PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment
16:45 - 18:00 | Presenter: Katrina Hueniken
- Abstract
Loading... -
+
P1.13-15 - Detection of EGFR Mutations in cfDNA and Development of Resistance
16:45 - 18:00 | Presenter: Grainne Mary O'Kane
- Abstract
Loading...
-
+
PL02 - Presidential Symposium - Top 5 Abstracts
- Type: Plenary Session
- Track: Advanced NSCLC
- Presentations: 11
- Coordinates: 9/25/2018, 08:15 - 09:45, Plenary Hall
-
+
PL02.08 - Discussant - PL02.07
09:10 - 09:15 | Presenter: Natasha B Leighl
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA14 - Survivorship, Socioeconomic and End-of-Life Considerations
- Type: Mini Oral Abstract Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Presentations: 12
- Coordinates: 9/25/2018, 10:30 - 12:00, Room 205 BD
-
+
MA14.06 - Predictors of Financial Toxicity, an Under-Recognized Patient-Reported Outcome
11:05 - 11:10 | Presenter: Doreen Anuli Ezeife
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA18 - Modelling, Decision-Making and Population-Based Outcomes
- Type: Mini Oral Abstract Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Presentations: 12
- Coordinates: 9/25/2018, 13:30 - 15:00, Room 201 F
-
+
MA18.07 - Awareness of the Harms of Continued Smoking Among Lung Cancer (LC) Survivors
14:05 - 14:10 | Presenter: Lawson Eng
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA18.09 - Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC.
14:25 - 14:30 | Presenter: Shirley Xue Jiang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 132
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.01-03 - Quality of Life Outcomes for FDA-Approved Agents in Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Hamzeh Albaba
- Abstract
Loading... -
+
P2.01-29 - Economic Analysis of Osimertinib in Previously Untreated EGFR-Positive Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Doreen Anuli Ezeife
- Abstract
Loading... -
+
P2.01-46 - Investigating the Effects of Prior Malignancy on NSCLC Trial Eligibility
16:45 - 18:00 | Presenter: Michael Herman
- Abstract
Loading... -
+
P2.01-94 - Diagnostic Patterns of Non-Small Cell Lung Cancer at Princess Margaret Cancer Centre
16:45 - 18:00 | Presenter: Mike Sung
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 37
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.03-03 - Upfront Next Generation Sequencing in NSCLC: A Publicly Funded Perspective
16:45 - 18:00 | Author(s): Tracy Stockley
- Abstract
Loading... -
+
P2.03-04 - Next Generation Sequencing in Lung Cancer Using the Oncomine Comprehensive Assay: The Canadian Publicly Funded Experience
16:45 - 18:00 | Author(s): Tracy Stockley
- Abstract
Loading...